• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 5, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Liver transplant, weight-loss surgery combination benefits obese patients in long term

Bioengineer by Bioengineer
October 2, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ROCHESTER, Minn. — Obese patients who underwent a life-saving liver transplant and weight-loss surgery at the same time were better able to keep the weight off long term and had fewer metabolic complications than those who lost weight on their own before undergoing a liver transplant, Mayo Clinic research shows. The findings were recently published in Hepatology.

"This study shows that the combined approach of liver transplantation and weight-loss surgery is safe and effective over the long term," says senior author Julie K. Heimbach, M.D., a transplant surgeon and division chair of Transplant Surgery at Mayo Clinic.

As obesity rates in the U.S. have soared, so have the number of people diagnosed with nonalcoholic fatty liver disease – a range of liver diseases that affects people who drink little to no alcohol and results in too much fat stored in liver cells. An estimated 80 to 100 million Americans have been diagnosed with this chronic liver disease. Historically, severely obese patients who are unable to lose the necessary weight have been denied access to a liver transplant because obesity can increase surgical risks and is a potential risk factor for post-transplant complications. In other instances, the transplants are performed without addressing a patient's weight problem, which can lead to liver disease in the future and jeopardize the success of the transplant.

The study involved a total of 49 adults with a body mass index of more than 35 kg/m2 who were referred to Mayo Clinic for a liver transplant since 2006. Of those patients, 36 were able to lose enough weight to achieve a BMI of less than 35 kg/m2 and underwent a liver transplant alone. Overall, there were 29 patients who were unable to lose sufficient weight prior to transplant and thus underwent a combined liver transplant and sleeve gastrectomy, with 13 of them being at least three years or more from the time of the surgery, which was the focus of the study. Sleeve gastrectomy is a type of weight-loss surgery that reduces the size of the stomach by about 80 percent.

Researchers found that, while patients who underwent the liver transplant alone experienced significant weight loss before surgery, they steadily gained weight afterwards. The percentage of total body weight gained ended up being higher among those patients who had the liver transplant alone compared to those who underwent both a liver transplant and sleeve gastrectomy. Three years after surgery, patients who had the liver transplant alone maintained a weight loss of a median of 3.9 percent of their total body weight compared to 34.8 percent for patients who had the transplant and weight-loss surgery. In addition, those patients who had the dual surgery were less likely to have high blood pressure, insulin resistance and fatty liver. They needed less medication to lower blood pressure and cholesterol.

"Obesity-related liver disease is one of the most common and rapidly increasing reasons that people need a liver transplant. Even though most obese people will not need a transplant, for those who develop advanced liver disease, we need to have an approach that treats not only the liver disease but the cause of the liver disease," says Dr. Heimbach.

###

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. Learn more about Mayo Clinic. Visit the Mayo Clinic News Network.

Media contact:

Heather Carlson Kehren, Mayo Clinic Public Affairs, 507-284-5005, [email protected]

Media Contact

Heather Carlson Kehren
[email protected]
507-284-5005
@MayoClinic

http://www.mayoclinic.org/news

https://newsnetwork.mayoclinic.org/discussion/long-term-benefits-for-obese-patients-that-undergo-combination-liver-transplant-and-weight-loss-surgery/

Share12Tweet7Share2ShareShareShare1

Related Posts

Midazolam Alone Often Fails in End-of-Life Sedation, French Cohort Reveals

Midazolam Alone Often Fails in End-of-Life Sedation, French Cohort Reveals

October 5, 2026
c-MET Signaling Reshapes the Lung Cancer Immune Landscape in Space and Metabolism

c-MET Signaling Reshapes the Lung Cancer Immune Landscape in Space and Metabolism

October 5, 2026

AI Chatbot Beats Web Search at Helping Laypeople Diagnose Respiratory Illness

October 5, 2026

Physics-Meets-AI Model Reads Muscle Fatigue Signals for Back Pain Rehab

October 5, 2026
Please login to join discussion

POPULAR NEWS

  • Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    29 shares
    Share 12 Tweet 7
  • Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

    29 shares
    Share 12 Tweet 7
  • Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

    29 shares
    Share 12 Tweet 7
  • New Scale Measures How Ready Nurse Educators Really Are for the AI Era

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.